Scientists test new shot to free HIV patients from daily pills
NCT ID NCT04983030
Summary
This study is testing a combination of an experimental HIV vaccine and lab-made antibodies in people who already have HIV and are taking daily medication. The goal is to see if this combination can help the body control the virus on its own, allowing participants to safely take a break from their regular pills. Researchers will carefully monitor participants' health and virus levels throughout the study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
Orlando Immunology Center
Orlando, Florida, 32803, United States
-
UCLA CARE (Center for AIDs Research and Education)
Los Angeles, California, 90035, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Washington Positive Research
Seattle, Washington, 98104, United States
-
Washington University Clinical Trials Unit
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.